Apathy and Functioning in First-Episode Psychosis
Faerden et al.
Psychiatr. Serv. 2009;60:1495-1503.
ABSTRACT
| FULL TEXT
Seeing the World Dimly: The Impact of Early Visual Deficits on Visual Experience in Schizophrenia
Kantrowitz et al.
Schizophr Bull 2009;35:1085-1094.
ABSTRACT
| FULL TEXT
Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research
Kirkbride et al.
Int J Epidemiol 2009;38:1255-1264.
ABSTRACT
| FULL TEXT
Taking the Perspective of the Other Contributes to Awareness of Illness in Schizophrenia
Langdon and Ward
Schizophr Bull 2009;35:1003-1011.
ABSTRACT
| FULL TEXT
Behavioral Signs of Schizoidia and Schizotypy in the Biological Parents of Social Anhedonics
Emmerson et al.
Behav Modif 2009;33:452-473.
ABSTRACT
Antecedents and Patterns of Suicide Behavior in First-Admission Psychosis
Bakst et al.
Schizophr Bull 2009;0:sbp001v1-sbp001.
ABSTRACT
| FULL TEXT
Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
Freedman et al.
Am. J. Psychiatry 2008;165:1040-1047.
ABSTRACT
| FULL TEXT
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Foussias and Remington
Schizophr Bull 2008;0:sbn094v1-sbn094.
ABSTRACT
| FULL TEXT
Reasoning Anomalies Associated With Delusions in Schizophrenia
Langdon et al.
Schizophr Bull 2008;0:sbn069v1-sbn069.
ABSTRACT
| FULL TEXT
Studying and Treating Schizophrenia Using Virtual Reality: A New Paradigm
Freeman
Schizophr Bull 2008;34:605-610.
ABSTRACT
| FULL TEXT
Theory of Mind and Schizophrenia: A Positron Emission Tomography Study of Medication-Free Patients
Andreasen et al.
Schizophr Bull 2008;34:708-719.
ABSTRACT
| FULL TEXT
Mental state decoding v. mental state reasoning as a mediator between cognitive and social function in psychosis
McGlade et al.
Br. J. Psychiatry 2008;193:77-78.
ABSTRACT
| FULL TEXT
Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
Buchanan et al.
Am. J. Psychiatry 2008;165:82-89.
ABSTRACT
| FULL TEXT
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments
Buchanan et al.
Am. J. Psychiatry 2007;164:1593-1602.
ABSTRACT
| FULL TEXT
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Goldberg et al.
Arch Gen Psychiatry 2007;64:1115-1122.
ABSTRACT
| FULL TEXT
Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial
Shim et al.
Am. J. Psychiatry 2007;164:1404-1410.
ABSTRACT
| FULL TEXT
Identifying Unmet Therapeutic Domains in Schizophrenia Patients: The Early Contributions of Wayne Fenton From Chestnut Lodge
McGlashan and Carpenter
Schizophr Bull 2007;33:1086-1092.
ABSTRACT
| FULL TEXT
Symptom rating scales and outcome in schizophrenia
Mortimer
Br. J. Psychiatry 2007;191:s7-s14.
ABSTRACT
| FULL TEXT
Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man
Boeijinga et al.
J Psychopharmacol 2007;21:321-337.
ABSTRACT
Asperger Syndrome and Medication Treatment
Tsai
Focus Autism Other Dev Disabl 2007;22:138-148.
ABSTRACT
Psychological effects of ketamine in healthy volunteers: Phenomenological study
Pomarol-Clotet et al.
Br. J. Psychiatry 2006;189:173-179.
ABSTRACT
| FULL TEXT
Food and Drug Administration Perspective on Negative Symptoms in Schizophrenia as a Target for a Drug Treatment Claim
Laughren and Levin
Schizophr Bull 2006;32:220-222.
ABSTRACT
| FULL TEXT
Anhedonia in Schizophrenia: A Review of Assessment Strategies
Horan et al.
Schizophr Bull 2006;32:259-273.
ABSTRACT
| FULL TEXT
The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
Blanchard and Cohen
Schizophr Bull 2006;32:238-245.
ABSTRACT
| FULL TEXT
Data Gathering: Biased in Psychosis?
Van Dael et al.
Schizophr Bull 2006;32:341-351.
ABSTRACT
| FULL TEXT
An Industry Perspective on the NIMH Consensus Statement on Negative Symptoms
Alphs
Schizophr Bull 2006;32:225-230.
ABSTRACT
| FULL TEXT
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick et al.
Schizophr Bull 2006;32:214-219.
FULL TEXT
Treatment of Schizophrenia Negative Symptoms: Future Prospects
Erhart et al.
Schizophr Bull 2006;32:234-237.
ABSTRACT
| FULL TEXT
Long-Term Course of Adolescent Schizophrenia
Fleischhaker et al.
Schizophr Bull 2005;31:769-780.
ABSTRACT
| FULL TEXT
Special Section on the GAF: Selection of Outcome Assessment Instruments for Inpatients With Severe and Persistent Mental Illness
Burlingame et al.
Psychiatr. Serv. 2005;56:444-451.
ABSTRACT
| FULL TEXT
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen et al.
Am. J. Psychiatry 2005;162:441-449.
ABSTRACT
| FULL TEXT
Incidence of bipolar affective disorder in three UK cities: Results from the AeSOP study
LLOYD et al.
Br. J. Psychiatry 2005;186:126-131.
ABSTRACT
| FULL TEXT
Facial Expressiveness in Patients With Schizophrenia Compared to Depressed Patients and Nonpatient Comparison Subjects
Tremeau et al.
Am. J. Psychiatry 2005;162:92-101.
ABSTRACT
| FULL TEXT
Olanzapine Treatment of Residual Positive and Negative Symptoms
Buchanan et al.
Am. J. Psychiatry 2005;162:124-129.
ABSTRACT
| FULL TEXT
Acute and transient psychotic disorders: precursors, epidemiology, course and outcome
Singh et al.
Br. J. Psychiatry 2004;185:452-459.
ABSTRACT
| FULL TEXT
Cumulative incidence of mental disorders among offspring of mothers with psychotic disorder: Results from the Helsinki High-Risk Study
Niemi et al.
Br. J. Psychiatry 2004;185:11-17.
ABSTRACT
| FULL TEXT
Schizophrenia and Other Psychotic Disorders
Jibson et al.
Focus 2004;2:17-30.
ABSTRACT
| FULL TEXT
Apathy in Schizophrenia: Reduced Frontal Lobe Volume and Neuropsychological Deficits
Roth et al.
Am. J. Psychiatry 2004;161:157-159.
ABSTRACT
| FULL TEXT
Monitoring and Care of Young People at Incipient Risk of Psychosis
Yung et al.
Focus 2004;2:158-174.
ABSTRACT
| FULL TEXT
Inferior Frontal White Matter Anisotropy and Negative Symptoms of Schizophrenia: A Diffusion Tensor Imaging Study
Wolkin et al.
Am. J. Psychiatry 2003;160:572-574.
ABSTRACT
| FULL TEXT
A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia
Mulholland et al.
J Psychopharmacol 2003;17:107-112.
ABSTRACT
Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold Symptoms
McGorry et al.
Arch Gen Psychiatry 2002;59:921-928.
ABSTRACT
| FULL TEXT
Rehab Rounds: A Service Response to Prolonged Recovery in Early Psychosis
Edwards et al.
Psychiatr. Serv. 2002;53:1067-1069.
ABSTRACT
| FULL TEXT
Visual Perceptual and Working Memory Impairments in Schizophrenia
Tek et al.
Arch Gen Psychiatry 2002;59:146-153.
ABSTRACT
| FULL TEXT
Disturbed Facial Affect Recognition in Patients With Schizophrenia Associated With Hypoactivity in Distributed Brain Regions: A Magnetoencephalographic Study
Streit et al.
Am. J. Psychiatry 2001;158:1429-1436.
ABSTRACT
| FULL TEXT
Neural Correlates of Formal Thought Disorder in Schizophrenia: Preliminary Findings From a Functional Magnetic Resonance Imaging Study
Kircher et al.
Arch Gen Psychiatry 2001;58:769-774.
ABSTRACT
| FULL TEXT
Neural Mechanisms of Anhedonia in Schizophrenia: A PET Study of Response to Unpleasant and Pleasant Odors
Crespo-Facorro et al.
JAMA 2001;286:427-435.
ABSTRACT
| FULL TEXT
Relationship Between Positive and Negative Symptoms of Schizophrenia and Schizotypal Symptoms in Nonpsychotic Relatives
Fanous et al.
Arch Gen Psychiatry 2001;58:669-673.
ABSTRACT
| FULL TEXT
Patterns and predictors of hospitalisation in first-episode psychosis: Prospective cohort study
SIPOS et al.
Br. J. Psychiatry 2001;178:518-523.
ABSTRACT
| FULL TEXT
Six-Month Outcomes for Patients Who Switched to Olanzapine Treatment
Noordsy et al.
Psychiatr. Serv. 2001;52:501-507.
ABSTRACT
| FULL TEXT
A Separate Disease Within the Syndrome of Schizophrenia
Kirkpatrick et al.
Arch Gen Psychiatry 2001;58:165-171.
ABSTRACT
| FULL TEXT
Effectiveness of an Attention- and Memory-Training Program on Neuropsychological Deficits in Schizophrenia
Kurtz et al.
Neurorehabil Neural Repair 2001;15:75-80.
ABSTRACT
Cognitive approach to depression and suicidal thinking in psychosis: I. Ontogeny of post-psychotic depression
BIRCHWOOD et al.
Br. J. Psychiatry 2000;177:516-528.
ABSTRACT
| FULL TEXT
Cognitive approach to depression and suicidal thinking in psychosis: 2. Testing the validity of a social ranking model
BIRCHWOOD et al.
Br. J. Psychiatry 2000;177:522-528.
ABSTRACT
| FULL TEXT
Clozapine Treatment of Outpatients With Schizophrenia: Outcome and Long-Term Response Patterns
Breier et al.
Psychiatr. Serv. 2000;51:1249-1253.
FULL TEXT
Volumetric Measure of the Frontal and Temporal Lobe Regions in Schizophrenia: Relationship to Negative Symptoms
Sanfilipo et al.
Arch Gen Psychiatry 2000;57:471-480.
ABSTRACT
| FULL TEXT
Use of Community Support Services by Middle-Aged and Older Patients With Psychotic Disorders
Shaw et al.
Psychiatr. Serv. 2000;51:506-512.
ABSTRACT
| FULL TEXT
Three-year outcome of first-episode psychoses in an established community psychiatric service
SINGH et al.
Br. J. Psychiatry 2000;176:210-216.
ABSTRACT
| FULL TEXT
Depressive Symptoms in Schizophrenia
Zisook et al.
Am. J. Psychiatry 1999;156:1736-1743.
ABSTRACT
| FULL TEXT
Empirical Validation of Primary Negative Symptoms: Independence From Effects of Medication and Psychosis
Kelley et al.
Am. J. Psychiatry 1999;156:406-411.
ABSTRACT
| FULL TEXT
From Pleasure to Anhedonia: Forbidden Desires and the Construction of Schizophrenia
Heinz and Heinze
Theory Psychology 1999;9:47-65.
ABSTRACT
Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response
Breier et al.
Am. J. Psychiatry 1999;156:294-298.
ABSTRACT
| FULL TEXT
Reduced Central Serotonin Transporters in Alcoholism
Heinz et al.
Am. J. Psychiatry 1998;155:1544-1549.
ABSTRACT
| FULL TEXT
Summer Birth and the Deficit Syndrome of Schizophrenia
Kirkpatrick et al.
Am. J. Psychiatry 1998;155:1221-1226.
ABSTRACT
| FULL TEXT
Apathy, Depression, and Cognitive Performance in HIV-1 Infection
Castellon et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:320-329.
ABSTRACT
| FULL TEXT
Psychopharmacological Treatment of Schizophrenia: What Social Workers Need to Know
Bentley
Research on Social Work Practice 1998;8:384-405.
ABSTRACT
Positive and Negative Symptom Response to Clozapine in Schizophrenic Patients With and Without the Deficit Syndrome
Buchanan et al.
Am. J. Psychiatry 1998;155:751-760.
ABSTRACT
| FULL TEXT
Auditory Hallucinations and the Temporal Cortical Response to Speech in Schizophrenia: A Functional Magnetic Resonance Imaging Study
Woodruff et al.
Am. J. Psychiatry 1997;154:1676-1682.
ABSTRACT
| FULL TEXT
Recent Advances in the Understanding of Negative Symptoms in Schizophrenia
Littrell and Littrell
J Am Psychiatr Nurses Assoc 1997;3:111-117.
ABSTRACT
Prediction of Compliance With Outpatient Referral in Patients With Schizophrenia and Psychoactive Substance Use Disorders
Miner et al.
Arch Gen Psychiatry 1997;54:706-712.
ABSTRACT
The Relationship Between Plasma Haloperidol Concentrations and Clinical Results
Palao et al.
Arch Gen Psychiatry 1996;53:1167-1168.
ABSTRACT
Maximizing Psychosocial Interventions
Littrell and Freeman
J Am Psychiatr Nurses Assoc 1995;1:214-218.
ABSTRACT
Behavioral vs Biochemical Prediction of Clinical Stability Following Haloperidol Withdrawal in Schizophrenia
van Kammen et al.
Arch Gen Psychiatry 1995;52:673-678.
ABSTRACT
Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen et al.
Arch Gen Psychiatry 1995;52:341-351.
ABSTRACT
A Longitudinal Study of Symptom Dimensions in Schizophrenia: Prediction and Patterns of Change
Arndt et al.
Arch Gen Psychiatry 1995;52:352-360.
ABSTRACT
Frontostriatal Disorder of Cerebral Metabolism in Never-Medicated Schizophrenics
Buchsbaum et al.
Arch Gen Psychiatry 1992;49:935-942.
ABSTRACT
Hypofrontality in Neuroleptic-Naive Patients and in Patients With Chronic Schizophrenia: Assessment With Xenon 133 Single-Photon Emission Computed Tomography and the Tower of London
Andreasen et al.
Arch Gen Psychiatry 1992;49:943-958.
ABSTRACT
The Comprehensive Assessment of Symptoms and History (CASH) An Instrument for Assessing Diagnosis and Psychopathology
Andreasen et al.
Arch Gen Psychiatry 1992;49:615-623.
ABSTRACT
Social Skills Training and Negative Symptoms
Matousek et al.
Behav Modif 1992;16:39-63.
ABSTRACT
The Positive-Negative Distinction in Schizophrenia: Review of Natural History Validators
McGlashan and Fenton
Arch Gen Psychiatry 1992;49:63-72.
ABSTRACT
Natural History of Schizophrenia Subtypes: II. Positive and Negative Symptoms and Long-term Course
Fenton and McGlashan
Arch Gen Psychiatry 1991;48:978-986.
ABSTRACT
Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
Arnold et al.
Arch Gen Psychiatry 1991;48:625-632.
ABSTRACT
Fluphenazine Dose, Clinical Response, and Extrapyramidal Symptoms During Acute Treatment
Levinson et al.
Arch Gen Psychiatry 1990;47:761-768.
ABSTRACT
Positive and Negative Symptoms in Schizophrenia: A Critical Reappraisal
Andreasen et al.
Arch Gen Psychiatry 1990;47:615-621.
ABSTRACT
Antecedents of Predominantly Negativeand Predominantly Positive-Symptom Schizophrenia in a High-Risk Population
Cannon et al.
Arch Gen Psychiatry 1990;47:622-632.
ABSTRACT
Norepinephrine in Acute Exacerbations of Chronic Schizophrenia: Negative Symptoms Revisited
van Kammen et al.
Arch Gen Psychiatry 1990;47:161-168.
ABSTRACT
Alprazolam Augmentation of Antipsychotic Pharmacotherapy?-Reply
Wolkowitz et al.
Arch Gen Psychiatry 1989;46:1052-1053.
ABSTRACT
Ventricle-Brain Ratio, Computed Tomographic Density, and Brain Area in 50 Schizophrenics
Pearlson et al.
Arch Gen Psychiatry 1989;46:690-697.
ABSTRACT
Cholinergic Hyperactivity and Negative Schizophrenic Symptoms: A Model of Cholinergic/Dopaminergic Interactions in Schizophrenia
Tandon and Greden
Arch Gen Psychiatry 1989;46:745-753.
ABSTRACT
Double-blind Comparison of Alprazolam, Diazepam, and Placebo for the Treatment of Negative Schizophrenic Symptoms
Csernansky et al.
Arch Gen Psychiatry 1988;45:655-659.
ABSTRACT
Brain imaging: applications in psychiatry
Andreasen
Science 1988;239:1381-1388.
ABSTRACT
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger
Arch Gen Psychiatry 1987;44:660-669.
ABSTRACT
